We wish we’d written that: STAT staffers share their favorite stories of 2024
In STAT’s “jealousy list” for 2024, STAT staffers explain what makes a selection of stories they read in other publications so compelling.
Related Articles
This PhD student helped to win a major pay hike for Canadian researchers
Nature – Kaitlin Kharas is part of Nature’s 10, a list of people who shaped science in 2024.
More Bystanders Are Using Naloxone to Save Folks From Overdose
MONDAY, Oct. 14, 2024 (HealthDay News) — More bystanders are stepping in to administer naloxone to people who’ve overdosed on opioids, a new study shows.Nearly
The yellow brick road to agentic AI
The road to agentic artificial intelligence will be paved with stepping stones that progressively build on each other.Our research suggests that agentic AI will not…
13 Reasons Why People Overeat
We all overeat sometimes. But when it happens more often than you might like, it can lead to unhealthy outcomes. Here are common reasons why…
The Benefits Hierarchy of Needs: Why Employers & Payers Should Prioritize Gut Health Benefits – MedCity News
These benefits set employees up with the resources and access to manage their health efficiently and proactively while giving employers financial savings throughout the year.
Most U.S. Adults Want to Be Asked About Mental Health at Primary Care Visits
MONDAY, Dec. 9, 2024 (HealthDay News) — Seven in 10 U.S. adults would prefer to be asked about both their physical and mental health during…
Healthier eating while dining out
Yes, it’s possible to eat healthy at almost any restaurant. Here are Mayo Clinic’s 7 tips for making smart food choices when dining out.
Do You Really Have HIGH BLOOD PRESSURE? How to check Blood Pressure Properly!
You might be falsely diagnosed with Hypertension when in reality your blood pressure is normal.This happens to so many people because doctor’s offices don’t …
Best of 2024: ASLeap: Higher Dose Secukinumab in Ankylosing Spondylitis | RheumNow
Ankylosing spondylitis (AS) patients not responding to usual dosing with secukinumab (150 mg) after 16 weeks were dose escalated to secukinumab (SEC) 300 mg, but…
How to Gain a Competitive Advantage with Cloud
Here’s how businesses can use the cloud to achieve a competitive advantage amid uncertainty.